SEMA7A and myeloid sarcoma: The levels of soluble Sema7A were significantly lower in the cerebrospinal fluid of patients with clinically isolated syndrome (CIS) who converted to clinically definite MS (CDMS) as compared to those who did not convert (Canto et al., 2014).